Fourteen studies unveiled at AUA 2024 demonstrate how decipher tests can aid in tailoring treatment for prostate and bladder cancer patients while also contributing to a deeper understanding of these diseases

South San Francisco: Veracyte, Inc., a leading cancer diagnostics company, has announced that data from 14 presentations at AUA 2024, the annual meeting of the American Urological Association, show that [...]